menu
    • menu

    Company profile for Kiromic BioPharma

    NEW Drugs in Dev: 6
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We are an immuno-oncology, target discovery and gene editing company developing highly effective and safe tumor-specific cancer engineered immunotherapies to face and defeat multiple cancer types. We are focused on extending the benefits of immunotherapy by leveraging DIAMOND AI (Kiromic Diamond Artificial Intelligence), that is a multi-purpose computational platform that can identify new cancer immunological targets for T-Ce...
    We are an immuno-oncology, target discovery and gene editing company developing highly effective and safe tumor-specific cancer engineered immunotherapies to face and defeat multiple cancer types. We are focused on extending the benefits of immunotherapy by leveraging DIAMOND AI (Kiromic Diamond Artificial Intelligence), that is a multi-purpose computational platform that can identify new cancer immunological targets for T-Cells and B-Cells.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Kiromic BioPharmaUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Fannin South Professional Building, 7707 Fannin St #140, Houston, TX 77054
    Telephone
    Telephone
    +1 (844) KEY-CURE
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://kiromic.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/kiromic
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    BPI Europe

    BPI Europe

    Not Confirmed

    envelop Contact Supplier

    BPI Europe

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Kiromic Reports 10-Month PFS For Patient 4 In Deltacel-01 Trial
    Kiromic Reports 10-Month PFS For Patient 4 In Deltacel-01 Trial

    18 Feb 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250218269453/en

    BUSINESSWIRE
    18 Feb 2025
    Share Share
    Kiromic Resolves Previously Disclosed SEC Investigation
    Kiromic Resolves Previously Disclosed SEC Investigation

    03 Dec 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241203898249/en

    BUSINESSWIRE
    03 Dec 2024
    Share Share
    Kiromic Reports Results From Deltacel-01 Enrolled Patients
    Kiromic Reports Results From Deltacel-01 Enrolled Patients

    08 Oct 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241008657194/en

    BUSINESSWIRE
    08 Oct 2024
    Share Share
    Kiromic BioPharma Advances Deltacel-01 Into Expansion Phase
    Kiromic BioPharma Advances Deltacel-01 Into Expansion Phase

    19 Sep 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240919396483/en

    BUSINESSWIRE
    19 Sep 2024
    Share Share
    Kiromic BioPharma Activates University Of Arizona Cancer Site
    Kiromic BioPharma Activates University Of Arizona Cancer Site

    19 Sep 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240919466768/en

    BUSINESSWIRE
    19 Sep 2024
    Share Share
    Kiromic BioPharma’s Deltacel Receives FDA Fast Track Designation
    Kiromic BioPharma’s Deltacel Receives FDA Fast Track Designation

    14 Aug 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240814382482/en

    BUSINESSWIRE
    14 Aug 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search